Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a

Marzia Lazzerini1, Simone Benvenuto2, Ilaria Mariani1

  • 1Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", 34137 Trieste, Italy.

Insights

Limited data exist on the SARS-CoV-2 (COVID-19) burden in children. Seroprevalence studies may not fully capture infection rates, highlighting the need for alternative markers like T cells.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Epidemiology

Background:

  • Data on the SARS-CoV-2 (COVID-19) pandemic's impact on children are scarce.
  • Assessing the true prevalence of infection in pediatric populations is challenging.

Purpose of the Study:

  • To evaluate the prevalence of SARS-CoV-2 IgG antibodies in children across three distinct time points.
  • To identify factors associated with seroconversion in the pediatric population.

Main Methods:

  • A cohort of 594 children was studied between January and July 2021.
  • SARS-CoV-2 IgG antibodies targeting the Spike protein were measured.
  • Multivariate logistic regression analyzed sociodemographic, clinical, and historical variables.

Main Results:

  • No significant trend in IgG antibody prevalence was observed over time (11.1% to 15.4%).
  • Children with prior positive nasopharyngeal swabs (AdjOR 15.41) or cohabiting with infected individuals (AdjOR 9.95) had higher odds of seropositivity.
  • Foreign citizenship was also associated with increased odds (AdjOR 2.4).

Conclusions:

  • Seroprevalence studies alone may be insufficient for estimating COVID-19 prevalence in children.
  • Further research is needed to explore alternative infection markers, such as CD4+ T cells and memory B-cells.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
894
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
753
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
482
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.5K